ArticleJournal of gynecologic oncology2026

Suppressor of TCR signaling 2 (Sts-2) as a potential immunotherapy target and prognostic biomarker in cervical cancer.

Yinlong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.